School of Medicine - Clinical MedicineHematology and Immunology

JapaneseEnglish

Website

We examine, treat and do research work for hematological disorders (for example, leukemia, lymphoma, and myeloma) and collagen-vascular disorders (for example, rheumatoid arthritis, systemic lupus erythematodes, Sjögren's syndrome, and vasculitis). We have been playing a central role in the study of IgG4-related disease in Japan. Furthermore, we are the research administration office for TAFRO syndrome, a rare and novel systemic inflammatory disease, with a grant from the Japanese Ministry of Health, Labour and Welfare.

Contact Information

TEL: 076-218-8158 +81-76-218-8158 / FAX: 076-286-9290 +81-76-286-9290 / Email: yasum@kanazawa-med.ac.jp

Faculty

Professor and Chair

  • MASAKI Yasufumi

Professor

  • FUKUSHIMA Toshihiro
  • KAWABATA Hiroshi
  • OKAZAKI Toshiro
  • MIZUTA Shuichi

Associate Professor

  • FUJITA Yoshimasa

Senior Assistant Professor

  • KAWANAMI Takafumi
  • SAKAI Tomoyuki

Assistant Professor

  • KAWANAMI(IWAO) Haruka
  • FUJIMOTO Shino

Research Achievements

Research Activities

  • Egami Y, Narushima Y, Ohshima M, Yoshida A, Yoneta N, Masaki Y, Itoh K:Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulphate proteoglycan 4. The Journal of Biochemistry, 163(1):61-68, 2018.
  • Kawabata H.:The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis. International Journal of Hematology, 107(1):31-43. 2018.
  • Masaki Y, Matsui S, Saeki T, Tsuboi H, Hirata S, Izumi Y, Miyashita T, Fujikawa K, Dobashi H, Susaki K, Morimoto H, Takagi K, Kawano M, Origuchi T, Wada Y, Takahashi N, Horikoshi M, Ogishima H, Suzuki Y, Kawanami T, Kawanami Iwao H, Sakai T, Fujita Y, Fukushima T, Saito M, Suzuki R, Morikawa Y, Yoshino T, Nakamura S, Kojima M, Kurose N, Sato Y, Tanaka Y, Sugai S, Sumida T: A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease. Modern Rheumatology, 27(5):849-854. 2017.
  • Masaki Y, Kawabata H, Takai K, Kojima M, Tsukamoto N, Ishigaki Y, Kurose N, Ide M, Murakami J, Nara K, Yamamoto H, Ozawa Y, Takahashi H, Miura K, Miyauchi T, Yoshida S, Momoi A, Awano N, Ikushima S, Ohta Y, Furuta N, Fujimoto S, Kawanami H, Sakai T, Kawanami T, Fujita Y, Fukushima T, Nakamura S, Kinoshita T, Aoki S: Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.International Journal of Hematology, 103(6):686-692, 2016.
  • Sakai T. et al. Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group, Medical Oncology , 32 (9):232-238, 2015.

External Research Funding

  • Health and Labour Sciences Research Grants for Research on Rare and Intractable Diseases (Research on TAFRO syndrome) from the Ministry of Health, Labour and Welfare of Japan; H27-Nanchi-Ippan-008)
  • JSPS KAKENHI Grant Number 15K09510, Grant-in-Aid for Scientific Research(C)
  • JSPS KAKENHI Grant Number 15K09511, Grant-in-Aid for Scientific Research(C)
  • JSPS KAKENHI Grant Number 15K09537, Grant-in-Aid for Scientific Research(C)